"Smart is recognizing an opportunity" Sentinel promo

Quote






First of all, thanks so much for publishing the promotional cost prices of this product online for clients to Google after their vet marks it up. Dummies.

Second, it's important you drug reps recognize Novartis is doing severe harm to the veterinary profession with this pricing scheme. Once diverters fill up online pharmacy shelves with Sentinel, you will have essentially set the maximum market tolerable profit for a year of both flea and heartworm prevention across the country at no more than $23.58 per dog.

Where did I come with that price?

Foster and Smith has ALREADY updated their Sentinel page with this message: "Item above on backorder. Expected in on 04/22/2013. Price: 51-100lb 12ct $83.88 11-25lb 12ct $54.96"

http://www.drsfostersmith.com/product/prod_display.cfm?pcatid=1460

You read that? "Expected on 4/22/13". They ALREADY HAVE DIVERTERS STANDING IN LINE BEGGING TO FILL THEIR SHELVES.

At an ongoing cost of $60.30/year (thanks again for publishing that on a public forum!), and a price of $83.88, per-dog profit for Sentinel will now only be $23.58, and any clinic that sets their prices above that will have angry clients and a fax full of prescription requests.

For 11-25lb dogs, at $54.96/12ct, profit drops to just $13.96/year/dog.

**$13.96/YEAR PROFIT.**

***For an entire YEAR of flea AND heartworm prevention***

I hope you all feel very proud of yourselves. When you walk into your clinics, may you get all the venom you deserve for trying to convince vets you're doing them a favor.

In one spectacular move, you've just lowered the net profits of every veterinary clinic in the country. Nicely done, guys.

Smart is recognizing Novartis Animal Health has just ruined an entire industry. You've ruined profits for everyone, you're the cheapest of the cheap, you've won the race to the bottom. Congratulations.
 






Anonymous said:
First of all, thanks so much for publishing the promotional cost prices of this product online for clients to Google after their vet marks it up. Dummies.

Second, it's important you drug reps recognize Novartis is doing severe harm to the veterinary profession with this pricing scheme. Once diverters fill up online pharmacy shelves with Sentinel, you will have essentially set the maximum market tolerable profit for a year of both flea and heartworm prevention across the country at no more than $23.58 per dog.

Where did I come with that price?

Foster and Smith has ALREADY updated their Sentinel page with this message: "Item above on backorder. Expected in on 04/22/2013. Price: 51-100lb 12ct $83.88 11-25lb 12ct $54.96"

http://www.drsfostersmith.com/product/prod_display.cfm?pcatid=1460

You read that? "Expected on 4/22/13". They ALREADY HAVE DIVERTERS STANDING IN LINE BEGGING TO FILL THEIR SHELVES.

At an ongoing cost of $60.30/year (thanks again for publishing that on a public forum!), and a price of $83.88, per-dog profit for Sentinel will now only be $23.58, and any clinic that sets their prices above that will have angry clients and a fax full of prescription requests.

For 11-25lb dogs, at $54.96/12ct, profit drops to just $13.96/year/dog.

**$13.96/YEAR PROFIT.**

***For an entire YEAR of flea AND heartworm prevention***

I hope you all feel very proud of yourselves. When you walk into your clinics, may you get all the venom you deserve for trying to convince vets you're doing them a favor.

In one spectacular move, you've just lowered the net profits of every veterinary clinic in the country. Nicely done, guys.

Smart is recognizing Novartis Animal Health has just ruined an entire industry. You've ruined profits for everyone, you're the cheapest of the cheap, you've won the race to the bottom. Congratulations.
Click to expand...

Hey moron -- we are doing them a favor. We are forcing the market to lower their prices. How is lower prices going to hurt a vet hospital? Lower vet prices on HW medication mean that now pet owners will be able to buy MORE than the just the average of 7 doses per year. Additionally, this will also allow vets to get more dogs on HW prevention than just the 50% they currently get. Pet owners now can also get other services that they coudn't previously afford. This is good for vets, pets, and pet owners. Who it's not good for? Distributor reps and Elanco and Meriap reps. Novartis is a THERAPEUTICS company that makes many meds for many diseases. You might want to beg your Novartis rep to let you know of any openings. Smart is working for the RIGHT company. Dumb is bitching about something you cannot control on an online website. Duche bag.
 












Lowering prices hurts a vet hospital (and you) because cost does not determine profitability.

2013: Selling $40 2-10lb Sentinel for $55 earns the hospital $15 profit.

2009: Selling $90 2-10lb Sentinel for $135 earns the hospital $45 profit.

Let's look at this from your point of view. Don't you make commission? If you're used to making $900 sales, do you think you'll make more, or less commission making $400 sales?

Yes, veterinary clients will be happier, because you're giving away the store. Yes, Elanco and Merial will be grumpy, because you're trying to make them cut their prices too, lowering industry profitability across the board.

You'll get to enjoy being the cheapest drug on the block for about five minutes. Undercutting is a race to the bottom that you do not want to win.

You're wrecking your own market, and you're proud of it. Who's the moron?
 






Wrecking our own market?? We are trying to get back in the market. Right now, we have zero marketshare. Whatever we get is new business. Remember, our sales last year were $0 for this category. We will now dominate the HW category and I love it!!
 






Yes, your plan is to win marketshare while simultaneously wrecking the entire industry's long-term income potential.

I mean, I totally get it. You're hungry, business is business, screw the other guy, nowhere to go but up... I can already imagine the self-congratulatory rah rah chest bumping at Novartis HQ. I totally get why you're jumping back into the market like this, because anything is better than zero. It's a painfully greedy approach, but it makes sense from a bottom-feeder standpoint.

But to win market share by undercutting the competition instead of based on the quality of the product, is a seriously short-sighted approach. You're claiming a bigger piece of the pie by shrinking the whole pie. Obviously, you're going to sell product, because vets are not good business people and will buy anything that's on sale. The more discount Sentinel gets sold over more expensive products, the more the pie will shrink.

You'll sell a bunch of product to a bunch of starving vets, they'll all congratulate themselves for lowering costs, clients will get used to paying $60 for their pet's prevention instead of $160. Then a year will go by, the vets will get their yearly P&L from their accountant, and they'll say "oh crap, our costs dropped, but so did our profits! And now my fax is full of freakin' Foster and Smith requests because I've trained my clients to Google everything I prescribe them, and I tried to try to make more than $14 on a year of heartworm and flea stuff. Dammit, Novartis, what have you done?!" But by then, it'll be too late.

And then what, Trifexis will start selling for $20/box? One way or the other, everybody else playing this game could choose to fight back against you and attempt to beat you to the bottom, because it's not like Sentinel is the Best Drug Ever, it's just... you know... adequate. Your competitors will regain their share of the pie you shrunk, and everybody will go home 40% poorer than before. And it will be all your fault.

Any vet reading this, think about this - if you sold Sentinel back in the day, did you also sell a bunch of Frontline with it, or did you just rely on the flea component of the Sentinel for the majority of your patients? Because if you're hoping to sell discount Sentinel and still make a profit, Novartis is counting on you to also sell their overpriced generic Frontline knockoff - I'm sorry, "Parastar Plus" - to make your profits, since you'll only be making pennies on your Sentinel. That's only going to last as long as it takes your clients to go remember they can get their real Frontline from Costco.

Vets, selling discount Sentinel is like undercutting the clinic down the block by charging $10 for a physical exam, instead of growing your practice by keeping your prices stable and practicing better medicine. It will come back to bite you. Screw this kamikaze scheme. These Novartis reps have their wallets in mind, and nobody else. Which, I realize, is the whole point of being a drug rep. Just... don't fall for it. Stick with whatever is currently keeping both your patients, and your accountant happy, for as long as you possibly can, until that shrunken pie strangles your choices.
 






Wow. Everyone is dumb. Even when we were selling Sentinel it only had an 8% market share, barly anything. We now are the same price as Heartgard and is now our main competition. So yes, about 500 clinics nationwide that used to be sentinel loyal accounts will be mad, but maybe they can sell it to more people and break even.

The only company that should be nervous is Merial, they are our target and is priced the same as us now. I doubt we will bring the whole business down since we barely had anyone on Sentinel to start. Interceptor was the biggest share and now we are same price as it. Every clinic in America that had interceptor won't realize any loss.

If I was the most expensive product, Trifexis, I would worry about everything. Good luck in that highest price spot, it nearly killed Sentinel years ago.

The end.
 












Anonymous said:
Yes, your plan is to win marketshare while simultaneously wrecking the entire industry's long-term income potential.

I mean, I totally get it. You're hungry, business is business, screw the other guy, nowhere to go but up... I can already imagine the self-congratulatory rah rah chest bumping at Novartis HQ. I totally get why you're jumping back into the market like this, because anything is better than zero. It's a painfully greedy approach, but it makes sense from a bottom-feeder standpoint.

But to win market share by undercutting the competition instead of based on the quality of the product, is a seriously short-sighted approach. You're claiming a bigger piece of the pie by shrinking the whole pie. Obviously, you're going to sell product, because vets are not good business people and will buy anything that's on sale. The more discount Sentinel gets sold over more expensive products, the more the pie will shrink.

You'll sell a bunch of product to a bunch of starving vets, they'll all congratulate themselves for lowering costs, clients will get used to paying $60 for their pet's prevention instead of $160. Then a year will go by, the vets will get their yearly P&L from their accountant, and they'll say "oh crap, our costs dropped, but so did our profits! And now my fax is full of freakin' Foster and Smith requests because I've trained my clients to Google everything I prescribe them, and I tried to try to make more than $14 on a year of heartworm and flea stuff. Dammit, Novartis, what have you done?!" But by then, it'll be too late.

And then what, Trifexis will start selling for $20/box? One way or the other, everybody else playing this game could choose to fight back against you and attempt to beat you to the bottom, because it's not like Sentinel is the Best Drug Ever, it's just... you know... adequate. Your competitors will regain their share of the pie you shrunk, and everybody will go home 40% poorer than before. And it will be all your fault.

Any vet reading this, think about this - if you sold Sentinel back in the day, did you also sell a bunch of Frontline with it, or did you just rely on the flea component of the Sentinel for the majority of your patients? Because if you're hoping to sell discount Sentinel and still make a profit, Novartis is counting on you to also sell their overpriced generic Frontline knockoff - I'm sorry, "Parastar Plus" - to make your profits, since you'll only be making pennies on your Sentinel. That's only going to last as long as it takes your clients to go remember they can get their real Frontline from Costco.

Vets, selling discount Sentinel is like undercutting the clinic down the block by charging $10 for a physical exam, instead of growing your practice by keeping your prices stable and practicing better medicine. It will come back to bite you. Screw this kamikaze scheme. These Novartis reps have their wallets in mind, and nobody else. Which, I realize, is the whole point of being a drug rep. Just... don't fall for it. Stick with whatever is currently keeping both your patients, and your accountant happy, for as long as you possibly can, until that shrunken pie strangles your choices.
Click to expand...

Ummm, the only thing you are forgetting is that the new low price will drive up compliance which means similar profits for vets. Why is that so hard to grasp? Additionally, pet owners should be more inclined to spend money in the clinic on other much needed services (i.e. - dentals, get dogs off steroids, blood work, hw tests, etc...). This helps Novartis and Novartis reps. It doesn't help the competition. It doesn't help distributors b/c Novartis doesn't pay them as much. I get why you're mad. Don't hate the player. Hate the game. You can always leave the industry.
 












Anonymous said:
Ummm, the only thing you are forgetting is that the new low price will drive up compliance which means similar profits for vets. Why is that so hard to grasp? Additionally, pet owners should be more inclined to spend money in the clinic on other much needed services (i.e. - dentals, get dogs off steroids, blood work, hw tests, etc...). This helps Novartis and Novartis reps. It doesn't help the competition. It doesn't help distributors b/c Novartis doesn't pay them as much. I get why you're mad. Don't hate the player. Hate the game. You can always leave the industry.
Click to expand...

Compliance will not go up. Never has, never will. It might in some clinics, but not nationwide. If Iverhart Plus and Triheart couldn't do it, why would Sentinel?
 






Anonymous said:
Compliance will not go up. Never has, never will. It might in some clinics, but not nationwide. If Iverhart Plus and Triheart couldn't do it, why would Sentinel?
Click to expand...

Sentinel had the highest compliance of any HW preventative at 9.3 months when it was 50% more epensive, what do you think it will be at a new low cost? I wish you were in my territory - It would be a blast destroying your credibility to vets on a daily basis.
 






Anonymous said:
Yes, your plan is to win marketshare while simultaneously wrecking the entire industry's long-term income potential.

I mean, I totally get it. You're hungry, business is business, screw the other guy, nowhere to go but up... I can already imagine the self-congratulatory rah rah chest bumping at Novartis HQ. I totally get why you're jumping back into the market like this, because anything is better than zero. It's a painfully greedy approach, but it makes sense from a bottom-feeder standpoint.

But to win market share by undercutting the competition instead of based on the quality of the product, is a seriously short-sighted approach. You're claiming a bigger piece of the pie by shrinking the whole pie. Obviously, you're going to sell product, because vets are not good business people and will buy anything that's on sale. The more discount Sentinel gets sold over more expensive products, the more the pie will shrink.

You'll sell a bunch of product to a bunch of starving vets, they'll all congratulate themselves for lowering costs, clients will get used to paying $60 for their pet's prevention instead of $160. Then a year will go by, the vets will get their yearly P&L from their accountant, and they'll say "oh crap, our costs dropped, but so did our profits! And now my fax is full of freakin' Foster and Smith requests because I've trained my clients to Google everything I prescribe them, and I tried to try to make more than $14 on a year of heartworm and flea stuff. Dammit, Novartis, what have you done?!" But by then, it'll be too late.

And then what, Trifexis will start selling for $20/box? One way or the other, everybody else playing this game could choose to fight back against you and attempt to beat you to the bottom, because it's not like Sentinel is the Best Drug Ever, it's just... you know... adequate. Your competitors will regain their share of the pie you shrunk, and everybody will go home 40% poorer than before. And it will be all your fault.

Any vet reading this, think about this - if you sold Sentinel back in the day, did you also sell a bunch of Frontline with it, or did you just rely on the flea component of the Sentinel for the majority of your patients? Because if you're hoping to sell discount Sentinel and still make a profit, Novartis is counting on you to also sell their overpriced generic Frontline knockoff - I'm sorry, "Parastar Plus" - to make your profits, since you'll only be making pennies on your Sentinel. That's only going to last as long as it takes your clients to go remember they can get their real Frontline from Costco.

Vets, selling discount Sentinel is like undercutting the clinic down the block by charging $10 for a physical exam, instead of growing your practice by keeping your prices stable and practicing better medicine. It will come back to bite you. Screw this kamikaze scheme. These Novartis reps have their wallets in mind, and nobody else. Which, I realize, is the whole point of being a drug rep. Just... don't fall for it. Stick with whatever is currently keeping both your patients, and your accountant happy, for as long as you possibly can, until that shrunken pie strangles your choices.
Click to expand...

Guessing you've never heard of Pet Trust Plus??? Sold only at Walmart and Sam's Club pharmacies. 50% Less expensive than Heartgard.
 






It is very obvious that some of the distributors posting here aren't working in the south, or they don't know what products they are actually selling. Either way, let me enlighten you on a product you are now selling, or you soon will be. Trash Parastar Plus at your own peril. You will soon look like a bafoon. Here is what I mean:

In 9 states in the south, Merial is selling their newest entrant into the flea and tick market, Frontline Tritak. National launch to the other states will be at some point this year. What is Tritak? Well, it's Parastar Plus, minus about 9% of the spreading agent and plus about 9% methoprene. That's right, distributors. Trash Parastar Plus and look like a fool when you return to those clinics to sell them our product in Frontline's box. Oh, Merial will try to spin it and say its their fipronil, they took over the plant, the carrier is patented and different, etc etc etc. The truth is this: we developed Parastar Plus with Seargants. Merial worked out a deal with Seargants to buy this product, add methoprene, and call it Tritak. It is packaged in the same plant where Parastar Plus is packaged. It's even packaged in the same tubes. Exact same tubes. Merial got approval for this new product by simply resubmitting studies already completed with Parastar Plus. They were able to do this because the EPA recognizes these two products as identical in composition and, identical in performance as an adulticide. Distributors, congrats. If you are already selling tritak, you are selling Parastar plus. If not, you soon will be. Go ahead. Call it trash. You will look so stupid when I come in behind you, show the same tubes, from the same factory. By the way, the numbers that identify which factory produced which product can be found on every box of every product the EPA regulates. They both come out of the same seargants factory in Nebraska. Did i mention they are even using our tubes? they aren't similar, they are exactly the same. Oh, and the frontline box costs about $5-7 more for what the EPA says is an identical product.

You guys are so smart.
 






Anonymous said:
Yes, your plan is to win marketshare while simultaneously wrecking the entire industry's long-term income potential.

I mean, I totally get it. You're hungry, business is business, screw the other guy, nowhere to go but up... I can already imagine the self-congratulatory rah rah chest bumping at Novartis HQ. I totally get why you're jumping back into the market like this, because anything is better than zero. It's a painfully greedy approach, but it makes sense from a bottom-feeder standpoint.

But to win market share by undercutting the competition instead of based on the quality of the product, is a seriously short-sighted approach. You're claiming a bigger piece of the pie by shrinking the whole pie. Obviously, you're going to sell product, because vets are not good business people and will buy anything that's on sale. The more discount Sentinel gets sold over more expensive products, the more the pie will shrink.

You'll sell a bunch of product to a bunch of starving vets, they'll all congratulate themselves for lowering costs, clients will get used to paying $60 for their pet's prevention instead of $160. Then a year will go by, the vets will get their yearly P&L from their accountant, and they'll say "oh crap, our costs dropped, but so did our profits! And now my fax is full of freakin' Foster and Smith requests because I've trained my clients to Google everything I prescribe them, and I tried to try to make more than $14 on a year of heartworm and flea stuff. Dammit, Novartis, what have you done?!" But by then, it'll be too late.

And then what, Trifexis will start selling for $20/box? One way or the other, everybody else playing this game could choose to fight back against you and attempt to beat you to the bottom, because it's not like Sentinel is the Best Drug Ever, it's just... you know... adequate. Your competitors will regain their share of the pie you shrunk, and everybody will go home 40% poorer than before. And it will be all your fault.

Any vet reading this, think about this - if you sold Sentinel back in the day, did you also sell a bunch of Frontline with it, or did you just rely on the flea component of the Sentinel for the majority of your patients? Because if you're hoping to sell discount Sentinel and still make a profit, Novartis is counting on you to also sell their overpriced generic Frontline knockoff - I'm sorry, "Parastar Plus" - to make your profits, since you'll only be making pennies on your Sentinel. That's only going to last as long as it takes your clients to go remember they can get their real Frontline from Costco.

Vets, selling discount Sentinel is like undercutting the clinic down the block by charging $10 for a physical exam, instead of growing your practice by keeping your prices stable and practicing better medicine. It will come back to bite you. Screw this kamikaze scheme. These Novartis reps have their wallets in mind, and nobody else. Which, I realize, is the whole point of being a drug rep. Just... don't fall for it. Stick with whatever is currently keeping both your patients, and your accountant happy, for as long as you possibly can, until that shrunken pie strangles your choices.
Click to expand...


Funny. The new Frontline, Frontline Tritak, is actually a Parastar plus knock off. That's hilarious. Distributors have been dogging Parastar plus since its launch, and now they will be selling a knock off version of it for $7 more. Life couldn't be funnier
 






Do you read what you write?? You mentioned s-metheprene and the pateneted spreading of the Fipronil. So, how are they identical if those are different. I am in the south and Tritak is going gangbusters. Parastar Plus, not so much!
 






Anonymous said:
Funny. The new Frontline, Frontline Tritak, is actually a Parastar plus knock off. That's hilarious. Distributors have been dogging Parastar plus since its launch, and now they will be selling a knock off version of it for $7 more. Life couldn't be funnier
Click to expand...

What's even funnier is when the Novartis reps show the veterinarian that s-methorpene degrades rapidly in sun light and water.....b/c....the $7 extra that they are paying for means that the dog can't go outside for it to actually be effective in killing fleas and larvae (which has to be a 100% kill or what's the point?).

Who was it again that ripped Sentinel and said that you can only use it on dogs that never go outside? Distributors continually prove how insiginificant they really are in this equation and yet they wonder why Novartis doesn't pay them equal to Elanco and Merial.

They are order takers. Nothing more and nothing less.
 






Anonymous said:
Do you read what you write?? You mentioned s-metheprene and the pateneted spreading of the Fipronil. So, how are they identical if those are different. I am in the south and Tritak is going gangbusters. Parastar Plus, not so much!
Click to expand...

Frontline Tritak is s-methorpene/fipronil/cyphenothrin.

Parastar Plus is fipronil/cyphenothrin.

Now partner up Sentinel and Parastar Plus. Compare that to Merial's Frontline Tritak and Heartgard.

Novartis wins on price and efficacy. Oh by the way....Sentinel gives the vet a chance against Walmart's knock off HG (sold at 50% reduction).

Face it distribution - either partner with Novartis, or get steam rolled.

Funny how you all laughed at us and maybe even had pity on us last year. Now you should be scared as hell of us. Those of us in the know at Novartis have been waiting for this time. Novartis is in cat bird's seat right now. Most of you are either too dumb or too ignorant to see it. You will though...Karma is a bitch huh?
 






Anonymous said:
Do you read what you write?? You mentioned s-metheprene and the pateneted spreading of the Fipronil. So, how are they identical if those are different. I am in the south and Tritak is going gangbusters. Parastar Plus, not so much!
Click to expand...

That's the point. There is no difference except the methoprene. Merial is saying they have a different spreading agent, however their approval was based on resubmitting Parastar Plus trials. Lets slow it down for you. The only way that is possible is if the products are drop for drop identical as far as the adulticidal activity goes. Notice that Merial makes no claims of how the methoprene improves performance? That's because they didn't do studies to show what benefit it adds. They just recycled our data as an adulticide, focusing on the speed of kill for fleas and ticks. They couldn't do it on their own with Certifect, so they had to backdoor a deal to get our product. If there was any sliver of difference between the two products, the EPA would have required them to do studies with their product, not submit ours. Are you paying attention? Or just drunk on the Merial kool aid?

Know what you are selling, distributors. It may help save you a little face in the long run. And, you never know how long your company will be in bed with Merial. Merial can't keep us locked out forever. Parastar Plus will be in your bag at some point.
 






Top Bottom
Back
Quote